Vés al contingut

A 26-Week, Randomized, Double-Blind, Placebo-Controlled, Multi-center Study to Evaluate the Efficacy, Safety, and Tolerability of Axatilimab in Subjects with Idiopathic Pulmonary Fibrosis (IPF)

Obert
  • Codi protocol: SNDX-6352-0506
  • Codi EudraCT: No aplica
  • Grup de recerca: Psiquiatria, Salut Mental i Addiccions
  • Servei: Psiquiatria
  • Investigador/a principal:  Villar Moreno, Ana M
  • Malaltia: Malalties del sistema respiratori
  • Fase: Fase II
  • Estat: Reclutant voluntaris